Affiliation: Memorial Sloan-Kettering Cancer Center
- Repeated courses of rituximab in chronic ITP: Three different regimensAisha Hasan
Division of Pediatric Hematology, Children s Blood Center, NY Presbyterian Hospital and Weill Cornell Medical College and Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Am J Hematol 84:661-5. 2009..Neither combining rituximab with CVP nor doubling the dose of rituximab increased the response rate...
- Artificial antigen presenting cells that express prevalent HLA alleles: A step towards the broad application of antigen-specific adoptive cell therapiesAisha N Hasan
Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Discov Med 8:210-8. 2009....
- Novel strategies for adoptive therapy following HLA disparate transplantsRICHARD J O'REILLY
Marrow Transplantation Program, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Best Pract Res Clin Haematol 24:381-91. 2011..These approaches may thus provide new, immediately accessible resources for the generation and broad application of immune cell therapies to treat and prevent severe viral diseases post transplant...
- Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or ViremiaGuenther Koehne
Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York Transplantation Biology Laboratory, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York Weill Cornell Medical College, New York, New York Electronic address
Biol Blood Marrow Transplant 21:1663-78. 2015..Thus, CMVpp65CTLs generated in response to synthetic 15-mer peptides of CMVpp65 are safe and can clear persistent CMV infections in the post-transplantation period...
- Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1(+) leukemiasEkaterina Doubrovina
Department of Pediatrics, Bone Marrow Transplantation Service and Division of Immunology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Blood 120:1633-46. 2012..This series of immunogenic epitopes of WT-1 should prove useful for immunotherapies targeting WT-1(+) malignancies...
- Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplantsRICHARD J O'REILLY
Department of Pediatrics, Memorial Sloan Kettering Cancer Institute, New York, NY, USA
Immunol Res 38:237-50. 2007..New more predictable strategies are under development, which should allow such therapies to be broadly applicable...
- Use of humanized severe combined immunodeficient mice for human vaccine developmentGloria C Koo
Department of Pediatrics, Memorial Sloan Kettering Cancer Center, NY 10021, USA
Expert Rev Vaccines 8:113-20. 2009..Human immune responses could be elicited and assessed in these humanized SCID mice upon vaccination or sensitization with allogeneic tissues. A translational model is proposed to attain preclinical data for testing human vaccines...